Terms: = Endocrine gland cancer AND DICER1, Dicer, 23405, ENSG00000100697, KIAA0928, HERNA, Q9UPY3, K12H4_8-LIKE AND Treatment
33 results:
1. Review on Sertoli-Leydig Cell Tumours of the Ovary.
Muscat C; Calleja-Agius J
Discov Med; 2024 Feb; 36(181):234-247. PubMed ID: 38409829
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease.
Rebollar-Vega RG; Zuarth-Vázquez JM; Hernández-Ramírez LC
Arch Med Res; 2023 Dec; 54(8):102899. PubMed ID: 37925320
[TBL] [Abstract] [Full Text] [Related]
3. Ascitic fluid shear stress in concert with hepatocyte growth factor drive stemness and chemoresistance of ovarian cancer cells via the c-Met-PI3K/Akt-miR-199a-3p signaling pathway.
Hassan AA; Artemenko M; Tang MKS; Shi Z; Chen LY; Lai HC; Yang Z; Shum HC; Wong AST
Cell Death Dis; 2022 Jun; 13(6):537. PubMed ID: 35676254
[TBL] [Abstract] [Full Text] [Related]
4. Genomic landscape of sporadic pediatric differentiated thyroid cancers: a systematic review and meta-analysis.
Satapathy S; Bal C
J Pediatr Endocrinol Metab; 2022 Jun; 35(6):749-760. PubMed ID: 35434981
[TBL] [Abstract] [Full Text] [Related]
5. VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patients.
Khan ANH; Emmons TR; Magner WJ; Alqassim E; Singel KL; Ricciuti J; Eng KH; Odunsi K; Tomasi TB; Lee K; Abrams SI; Mesa C; Segal BH
Cancer Immunol Immunother; 2022 Oct; 71(10):2355-2369. PubMed ID: 35166871
[TBL] [Abstract] [Full Text] [Related]
6. High Prevalence of Gene Fusions and Copy Number Alterations in Pediatric Radiation Therapy-Induced Papillary and Follicular Thyroid Carcinomas.
Hess JR; Newbern DK; Beebe KL; Walsh AM; Schafernak KT
Thyroid; 2022 Apr; 32(4):411-420. PubMed ID: 34915766
[No Abstract] [Full Text] [Related]
7. Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents.
Schneider DT; Orbach D; Ben-Ami T; Bien E; Bisogno G; Brecht IB; Cecchetto G; Ferrari A; Godzinski J; Janic D; Lopez Almaraz R; Pourtsidis A; Roganovic J; Schultz KAP; Stachowicz-Stencel T; Fresneau B
Pediatr Blood Cancer; 2021 Jun; 68 Suppl 4():e29017. PubMed ID: 33760357
[TBL] [Abstract] [Full Text] [Related]
8. Molecular characterization of dicer1-mutated pituitary blastoma.
Nadaf J; de Kock L; Chong AS; Korbonits M; Thorner P; Benlimame N; Fu L; Peet A; Warner J; Ploner O; Shuangshoti S; Albrecht S; Hamel N; Priest JR; Rivera B; Ragoussis J; Foulkes WD
Acta Neuropathol; 2021 Jun; 141(6):929-944. PubMed ID: 33644822
[TBL] [Abstract] [Full Text] [Related]
9. Genetic variants and risk of thyroid cancer among Iranian patients.
Jamshidi M; Farnoosh G; Mohammadi Pour S; Rafiee F; Saeedi Boroujeni A; Mahmoudian-Sani MR
Horm Mol Biol Clin Investig; 2021 Feb; 42(2):223-234. PubMed ID: 33544997
[TBL] [Abstract] [Full Text] [Related]
10. The clinical aspects of pituitary tumour genetics.
Dénes J; Korbonits M
Endocrine; 2021 Mar; 71(3):663-674. PubMed ID: 33543431
[TBL] [Abstract] [Full Text] [Related]
11. ERK-mediated transcriptional activation of dicer is involved in gemcitabine resistance of pancreatic cancer.
Su YH; Hsu TW; Chen HA; Su CM; Huang MT; Chuang TH; Leo Su J; Hsieh CL; Chiu CF
J Cell Physiol; 2021 Jun; 236(6):4420-4434. PubMed ID: 33184874
[TBL] [Abstract] [Full Text] [Related]
12. Macrofollicular Variant of Follicular Thyroid Carcinoma (MV-FTC) with a Somatic dicer1 Gene Mutation: Case Report and Review of the Literature.
Hellgren LS; Hysek M; Jatta K; Zedenius J; Juhlin CC
Head Neck Pathol; 2021 Jun; 15(2):668-675. PubMed ID: 32712880
[TBL] [Abstract] [Full Text] [Related]
13. Sertoli-Leydig cell tumor in two siblings with dicer1 syndrome: A case report and literature review.
Zhang Y; Ren M; Hong Y; Zhong Y; Cong X; Chen C; Liu Z; Man Y; Yang L
Medicine (Baltimore); 2020 Jul; 99(27):e20806. PubMed ID: 32629665
[TBL] [Abstract] [Full Text] [Related]
14. [Virilizing ovarian tumor: the challenges of differential diagnosis].
Kalashnikova MF; Likhodey NV; Tiulpakov AN; Fedorova EV; Bryunin DV; Bakhvalova AA; Glushakova MA; Smirnova SA; Fadeyev VV
Probl Endokrinol (Mosk); 2019 Dec; 65(4):273-277. PubMed ID: 32202730
[TBL] [Abstract] [Full Text] [Related]
15. Gynecologic and reproductive health in patients with pathogenic germline variants in dicer1.
Merideth MA; Harney LA; Vyas N; Bachi A; Carr AG; Hill DA; Dehner LP; Schultz KAP; Stewart DR; Stratton P
Gynecol Oncol; 2020 Mar; 156(3):647-653. PubMed ID: 31952842
[TBL] [Abstract] [Full Text] [Related]
16. Pituitary tumours in MEN1 syndrome - the new insight into the diagnosis and treatment.
Rogoziński D; Gilis-Januszewska A; Skalniak A; Kluczyński Ł; Pantofliński J; Hubalewska-Dydejczyk A
Endokrynol Pol; 2019; 70(5):445-452. PubMed ID: 31681967
[TBL] [Abstract] [Full Text] [Related]
17. Genetics of Pituitary Tumours.
Loughrey PB; Korbonits M
Exp Suppl; 2019; 111():171-211. PubMed ID: 31588533
[TBL] [Abstract] [Full Text] [Related]
18. Androgen-Secreting Ovarian Tumors.
Macut D; Ilić D; Mitrović Jovanović A; Bjekić-Macut J
Front Horm Res; 2019; 53():100-107. PubMed ID: 31499493
[TBL] [Abstract] [Full Text] [Related]
19. Sertoli-Leydig cell tumor of the ovary: Analysis of a single institution database and review of the literature.
Durmuş Y; Kılıç Ç; Çakır C; Yüksel D; Boran N; Karalök A; Boyraz G; Turan AT
J Obstet Gynaecol Res; 2019 Jul; 45(7):1311-1318. PubMed ID: 31106943
[TBL] [Abstract] [Full Text] [Related]
20. Clinical and Molecular Characteristics May Alter treatment Strategies of Thyroid Malignancies in dicer1 Syndrome.
van der Tuin K; de Kock L; Kamping EJ; Hannema SE; Pouwels MM; Niedziela M; van Wezel T; Hes FJ; Jongmans MC; Foulkes WD; Morreau H
J Clin Endocrinol Metab; 2019 Feb; 104(2):277-284. PubMed ID: 30260442
[TBL] [Abstract] [Full Text] [Related]
[Next]
